HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1198
https://www.valueinhealthjournal.com/article/S1098-3015(23)01298-6/fulltext
Title :
HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01298-6&doi=10.1016/j.jval.2023.03.1198
First page :
Section Title :
Open access? :
No
Section Order :
10635